MetLife Investment Management’s Real Brokerage REAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$112K Sell
44,626
-30,820
-41% -$93.2K ﹤0.01% 2491
2025
Q4
$275K Buy
75,446
+19,335
+34% +$74.7K ﹤0.01% 2114
2025
Q3
$235K Sell
56,111
-9,639
-15% -$43.5K ﹤0.01% 2228
2025
Q2
$297K Hold
65,750
﹤0.01% 1965
2025
Q1
$267K Sell
65,750
-713
-1% -$3.38K ﹤0.01% 2044
2024
Q4
$306K Buy
66,463
+9,662
+17% +$50.7K ﹤0.01% 2063
2024
Q3
$315K Buy
56,801
+32,005
+129% +$182K ﹤0.01% 2039
2024
Q2
$101K Buy
+24,796
New +$104K ﹤0.01% 2601

Other funds holding REAX

MetLife Investment Management's REAX Position: Q1 2026 in Review

MetLife Investment Management reduced its Real Brokerage (REAX) stake by 41% in Q1 2026, selling an estimated $93.2K and leaving 44,626 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #2491.

MetLife Investment Management first reported a position in REAX in Q2 2024 and has held it in 8 quarters since. The position peaked at $315K in Q3 2024. 159 funds tracked by Wall St. Rank hold REAX as of Q1 2026.

  • MetLife Investment Management held 44,626 shares of Real Brokerage worth $112K as of Q1 2026.
  • MetLife Investment Management sold 30,820 Real Brokerage shares in Q1 2026, an estimated $93.2K.
  • Real Brokerage made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2491 holding.
  • MetLife Investment Management first reported a position in Real Brokerage in Q2 2024 and has held it in 8 quarters since.
  • MetLife Investment Management's Real Brokerage position peaked at $315K in Q3 2024.
  • 159 funds tracked by Wall St. Rank held Real Brokerage as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.